Asia Pacific Intracranial Aneurysm Market Report and Forecast 2024-2032

Asia Pacific Intracranial Aneurysm Market Report and Forecast 2024-2032


Asia Pacific Intracranial Aneurysm Market Report and Forecast 2024-2032

Asia Pacific Intracranial Aneurysm Market Outlook

The global intracranial aneurysm market size was valued at USD 1.2 billion in 2023, with Asia Pacific holding a significant market share. The market is driven by technological advances in surgical approaches and increased healthcare access. It is expected to grow at a CAGR of 9.3% during the forecast period of 2024-2032, with the values likely to attain USD 2.6 billion by 2032.

Key Takeaways
  • Recent data reveals that intracranial aneurysm is a common cerebrovascular disease, with a prevalence of 3.2% and 7% estimated in the global population and China , respectively. The rising cases of intracranial aneurysms directly impact the market demand.
  • One of the major Asia Pacific intracranial aneurysm market trends is the rise in clinical studies to enhance medical device design and usage for treating intracranial aneurysms. For instance, INSPIRE-A is an international registry sponsored by Medtronic plc that enables standardized assessment of flow-diverter imaging results in endovascular aneurysm care.
  • The market share is positively influenced by the advancement in diagnostic techniques. In April 2024, a study published in the Lancet revealed that a team of Chinese researchers developed a CT angiography (CTA)-based AI model for intracranial aneurysm detection, showing robust clinical potential in detecting the aneurysm.
Asia Pacific Intracranial Aneurysm Market Analysis

An intracranial aneurysm, also known as cerebral or brain aneurysm, is characterized by the presence of a bulge or ballooning in a blood vessel in the brain. Often developed at points in arteries where the vessel wall is weakened, the rupturing of an aneurysm can result in bleeding into the brain or the surrounding areas. This can cause stroke, brain damage, or even death if immediate treatment is not provided to the patient. There is a growing demand for minimally invasive surgical techniques such as endovascular coiling and flow diversion, which greatly reduce the risk of complications and improve patient outcomes. The rising availability of such treatments due to increased public and private sector investments is expected to drive the Asia Pacific intracranial aneurysm market growth.

In Asia Pacific, the rising cases of intracranial aneurysms can be attributed to the growing aging populations, increased smoking, and other lifestyle-related health issues. Recent data reveals that intracranial aneurysm is a common cerebrovascular disease, with a prevalence of 3.2% and 7% estimated in the global population and China, respectively. Subarachnoid hemorrhage, which is primarily caused by aneurysmal rupture, has a case fatality of 50%, which indicates the critical need for effective treatment interventions. Thus, with the growing prevalence rate of the condition, the Asia Pacific intracranial aneurysm market demand is likely to witness a surge.

One of the major market trends is the rise in clinical studies to enhance the design and usage of medical devices for treating intracranial aneurysms and improve patient outcomes. For instance, INSPIRE-A is an international registry sponsored by Medtronic plc that enables standardized assessment of flow-diverter imaging results in endovascular aneurysm care. The registry, with over 1,400 participants enrolled from more than 40 sites such as in China and Australia, monitors and evaluates outcomes in intracranial aneurysm patients, treated with Medtronic neurovascular medical devices. The findings from such global registries are expected to offer insights into the performance of flow diverters, influencing clinical guidelines and elevating the Asia Pacific intracranial aneurysm market value significantly in the forecast period.

The market is also influenced by the advancement in diagnostic techniques facilitating the early detection and accurate diagnosis of intracranial aneurysms. A study published in the Lancet in April 2024 revealed that a team of Chinese researchers developed a CT angiography (CTA)-based AI model for intracranial aneurysm detection. The early-stage clinical validation study reported that the deep-learning model exhibited robust clinical potential in detecting the aneurysm as well as improved diagnostic performance and practical implementation in real-world settings. The adoption of such innovative diagnostic technologies is anticipated to accelerate market growth in the coming years.

Asia Pacific Intracranial Aneurysm Market Segmentation  

Market Breakup by Treatment Type
  • Endovascular Coiling
  • Surgical Clipping
  • Flow Diverters
  • Other Treatment Types
Market Breakup by End User
  • Hospitals
  • Clinics
  • Others
Market Breakup by Countries
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others
Asia Pacific Intracranial Aneurysm Market: Competitor Landscape

The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Medtronic
  • Stryker
  • MicroPort Scientific Corporation
  • Johnson & Johnson Services, Inc.
  • MicroVention Inc.
  • Integra LifeSciences
  • B. Braun Melsungen AG
  • RAUMEDIC AG
  • Mizuho Medical Co. Ltd.
  • Penumbra, Inc.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

FAQs
  • What is the Asia Pacific intracranial aneurysm market forecast outlook for 2024-2032?
The Asia Pacific intracranial aneurysm market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 8.8% during the forecast period of 2024-2032 and is likely to reach a market value of USD 2.6 billion by 2032.
  • What are the major factors aiding the Asia Pacific intracranial aneurysm market demand?
The rising demand for minimally invasive surgical techniques such as endovascular coiling and flow diversion is fuelling the demand for the market.
  • What are the major Asia Pacific intracranial aneurysm market trends?
One of the significant trends in the market is the rise in clinical studies to enhance medical device design and usage for treating intracranial aneurysms. For instance, INSPIRE-A is an international registry sponsored by Medtronic plc that enables standardized assessment of flow-diverter imaging results in endovascular aneurysm care.
  • What is the market segmentation based on the treatment type?
Based on the treatment type, the market is segmented into endovascular coiling, surgical clipping, and flow diverters, among other treatment types.
  • What are the major end users of the market?
End users of the market are hospitals and clinics, among other end-users.
  • What is the market segmentation by countries?
The market segmentation by countries includes China, Japan, India, ASEAN, and Australia, among others.
  • Who are the key players involved in the Asia Pacific intracranial aneurysm market?
The key players in the market are Medtronic, Stryker, MicroPort Scientific Corporation, Johnson & Johnson Services, Inc., MicroVention Inc., Integra LifeSciences, B. Braun Melsungen AG, RAUMEDIC AG, Mizuho Medical Co. Ltd., and Penumbra, Inc.

Meta description

The Asia Pacific intracranial aneurysm market is poised for growth, driven by the expansion of the global market, which was valued at USD 1.2 billion in 2023 and is projected to grow at a CAGR of 8.8% during the forecast period of 2024-2032.

*Please Note:* The report will take 7 business days to complete, after order confirmation.


1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Asia Pacific Intracranial Aneurysm Market Overview
3.1 Asia Pacific Intracranial Aneurysm Market Historical Value (2017-2023)
3.2 Asia Pacific Intracranial Aneurysm Market Forecast Value (2024-2032)
4 Asia Pacific Intracranial Aneurysm Market Landscape*
4.1 Asia Pacific Intracranial Aneurysm Market: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Asia Pacific Intracranial Aneurysm Market: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Material
4.2.3 Analysis by Type
5 Asia Pacific Intracranial Aneurysm Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Asia Pacific Intracranial Aneurysm Market Segmentation (2017-2032)
6.1 Asia Pacific Intracranial Aneurysm Market (2017-2032) by Treatment Type
6.1.1 Market Overview
6.1.2 Endovascular Coiling
6.1.3 Surgical Clipping
6.1.4 Flow Diverters
6.1.5 Other Treatment Types
6.2 Asia Pacific Intracranial Aneurysm Market (2017-2032) by End User
6.2.1 Market Overview
6.2.2 Hospitals
6.2.3 Clinics
6.2.4 Other end-users
6.3 Asia Pacific Intracranial Aneurysm Market (2017-2032) by Countries
6.3.1 Market Overview
6.3.2 China
6.3.3 Japan
6.3.4 ASEAN
6.3.5 Australia
6.3.6 India
6.3.7 Others
7 China Intracranial Aneurysm Market (2017-2032)
7.1 China Intracranial Aneurysm Market (2017-2032) by Treatment Type
7.1.1 Market Overview
7.1.2 Endovascular Coiling
7.1.3 Surgical Clipping
7.1.4 Flow Diverters
7.1.5 Other Treatment Types
7.2 China Intracranial Aneurysm Market (2017-2032) by End Use
7.2.1 Market Overview
7.2.2 Hospitals
7.2.3 Clinics
7.2.4 Other end-users
8 Japan Intracranial Aneurysm Market (2017-2032)
8.1 Japan Intracranial Aneurysm Market (2017-2032) by Treatment Type
8.1.1 Market Overview
8.1.2 Endovascular Coiling
8.1.3 Surgical Clipping
8.1.4 Flow Diverters
8.1.5 Other Treatment Types
8.2 Japan Intracranial Aneurysm Market (2017-2032) by End Use
8.2.1 Market Overview
8.2.2 Hospitals
8.2.3 Clinics
8.2.4 Other end-users
9 ASEAN Intracranial Aneurysm Market (2017-2032)
9.1 ASEAN Intracranial Aneurysm Market (2017-2032) by Treatment Type
9.1.1 Market Overview
9.1.2 Endovascular Coiling
9.1.3 Surgical Clipping
9.1.4 Flow Diverters
9.1.5 Other Treatment Types
9.2 ASEAN Intracranial Aneurysm Market (2017-2032) by End Use
9.2.1 Market Overview
9.2.2 Hospitals
9.2.3 Clinics
9.2.4 Other End-Users
10 Australia Intracranial Aneurysm Market (2017-2032)
10.1 Australia Intracranial Aneurysm Market (2017-2032) by Treatment Type
10.1.1 Market Overview
10.1.2 Endovascular Coiling
10.1.3 Surgical Clipping
10.1.4 Flow Diverters
10.1.5 Other Treatment Types
10.2 Australia Intracranial Aneurysm Market (2017-2032) by End Use
10.2.1 Market Overview
10.2.2 Hospitals
10.2.3 Clinics
10.2.4 Other End-Users
11 India Aneurysm Market (2017-2032)
11.1 India Intracranial Aneurysm Market (2017-2032) by Treatment Type
11.1.1 Market Overview
11.1.2 Endovascular Coiling
11.1.3 Surgical Clipping
11.1.4 Flow Diverters
11.1.5 Other Treatment Types
11.2 India Intracranial Aneurysm Market (2017-2032) by End Use
11.2.1 Market Overview
11.2.2 Hospitals
11.2.3 Clinics
11.2.4 Other End-Users
12 Regulatory Framework
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Funding and Investment Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Supplier Landscape
16.1 Market Share by Top 5 Companies
16.2 Medtronic
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Mergers and Acquisitions
16.2.5 Certifications
16.3 Stryker
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Mergers and Acquisitions
16.3.5 Certifications
16.4 MicroPort Scientific Corporation
16.4.1 Financial Analysis
16.4.2 Product Portfolio
16.4.3 Demographic Reach and Achievements
16.4.4 Mergers and Acquisitions
16.4.5 Certifications
16.5 Johnson & Johnson Services, Inc.
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Mergers and Acquisitions
16.5.5 Certifications
16.6 MicroVention Inc.
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Mergers and Acquisitions
16.6.5 Certifications
16.7 Integra LifeSciences
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Mergers and Acquisitions
16.7.5 Certifications
16.8 B. Braun Melsungen AG
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Mergers and Acquisitions
16.8.5 Certifications
16.9 RAUMEDIC AG
16.9.1 Financial Analysis
16.9.2 Product Portfolio
16.9.3 Demographic Reach and Achievements
16.9.4 Mergers and Acquisitions
16.9.5 Certifications
16.10 Mizuho Medical Co. Ltd.
16.10.1 Financial Analysis
16.10.2 Product Portfolio
16.10.3 Demographic Reach and Achievements
16.10.4 Mergers and Acquisitions
16.10.5 Certifications
16.11 Penumbra, Inc.
16.11.1 Financial Analysis
16.11.2 Product Portfolio
16.11.3 Demographic Reach and Achievements
16.11.4 Mergers and Acquisitions
16.11.5 Certifications
17 Asia Pacific Intracranial Aneurysm Market – Distribution Model (Additional Insight)
17.1 Overview
17.2 Potential Distributors
17.3 Key Parameters for Distribution Partner Assessment
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings